The Transformer database: biotransformation of xenobiotics

被引:54
作者
Hoffmann, Michael F.
Preissner, Sarah C.
Nickel, Janette
Dunkel, Mathias
Preissner, Robert
Preissner, Saskia [1 ]
机构
[1] Charite, Struct Bioinformat Grp, Inst Physiol, D-13125 Berlin, Germany
关键词
ADVERSE DRUG-REACTIONS; GRAPEFRUIT JUICE; PHARMACOGENOMICS; POLYPHARMACY; PRODRUGS; ENZYMES; GENE; NEED;
D O I
10.1093/nar/gkt1246
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As the number of prescribed drugs is constantly rising, drug-drug interactions are an important issue. The simultaneous administration of several drugs can cause severe adverse effects based on interactions with the same metabolizing enzyme(s). The Transformer database (http://bioinformatics.charite.de/transformer) contains integrated information on the three phases of biotransformation (modification, conjugation and excretion) of 3000 drugs and >350 relevant food ingredients (e. g. grapefruit juice) and herbs, which are catalyzed by 400 proteins. A total of 100 000 interactions were found through text mining and manual validation. The 3D structures of 200 relevant proteins are included. The database enables users to search for drugs with a visual display of known interactions with phase I (Cytochrome P450) and phase II enzymes, transporters, food and herbs. For each interaction, PubMed references are given. To detect mutual impairments of drugs, the drug-cocktail tool displays interactions between selected drugs. By choosing the indication for a drug, the tool offers suggestions for alternative medications to avoid metabolic conflicts. Drug interactions can also be visualized in an interactive network view. Additionally, prodrugs, including their mechanisms of activation, and further information on enzymes of biotransformation, including 3D models, can be viewed.
引用
收藏
页码:D1113 / D1117
页数:5
相关论文
共 29 条
[1]   CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].
ALBERT, A .
NATURE, 1958, 182 (4633) :421-423
[2]   The prevalence of polypharmacy in elderly attenders to an emergency department - A problem with a need for an effective solution [J].
Banerjee A. ;
Mbamalu D. ;
Ebrahimi S. ;
Khan A.A. ;
Chan T.F. .
International Journal of Emergency Medicine, 4 (1)
[3]  
Bressler R, 2006, GERIATRICS, V61, P12
[4]   Using photolabile ligands in drug discovery and development [J].
Dormán, G ;
Prestwich, GD .
TRENDS IN BIOTECHNOLOGY, 2000, 18 (02) :64-77
[5]   Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity [J].
Guengerich, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (06) :611-650
[6]  
He Lei, 2009, Human Genomics, V3, P195
[7]   Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery [J].
Huttunen, Kristiina M. ;
Mahonen, Niina ;
Raunio, Hannu ;
Rautio, Jarkko .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (23) :2346-2365
[8]   Pharmacogenomics of the human ABC transporter ABCG2: From functional evaluation to drug molecular design [J].
Ishikawa, T ;
Tamura, A ;
Saito, H ;
Wakabayashi, K ;
Nakagawa, H .
NATURWISSENSCHAFTEN, 2005, 92 (10) :451-463
[9]  
JAKOBY WB, 1990, J BIOL CHEM, V265, P20715
[10]   The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so [J].
Kell, Douglas B. ;
Dobson, Paul D. ;
Bilsland, Elizabeth ;
Oliver, Stephen G. .
DRUG DISCOVERY TODAY, 2013, 18 (5-6) :218-239